Protein C deficiency as the major cause of thrombophilias in childhood

Pediatr Int. 2013 Jun;55(3):267-71. doi: 10.1111/ped.12102.

Abstract

Genetic predisposition of thromboembolism depends on the racial background. Factor V Leiden (G1691A) and factor II mutation (G20210A) are the leading causes of inherited thrombophilias in Caucasians, but are not found in Asian ancestries. Protein S (PS), protein C (PC) and antithrombin (AT) activity are reportedly low in 65% of adult Japanese patients with deep vein thrombosis. Approximately half of the patients with each deficiency carry the heterozygous mutation of PS (PROS1; 20%), PC (PROC; 10%), and AT genes (SERPINC1: 5%). Recently, several studies have revealed an outline of inherited thrombophilias in Japanese children. Congenital thrombophilias in 48 patients less than age 20 years consisted of 45% PC deficiency, 15% PS deficiency and 10% AT deficiency, along with other causes. All PS- and AT-deficient patients had a heterozygous mutation of the respective gene. On the other hand, PC-deficient patients were considered to carry the homozygous or compound heterozygous mutation in 50%, the heterozygous mutation in 25%, and unknown causes in the remaining 25% of patients. Half of unrelated patients with homozygous or compound heterozygous PROC mutations carried PC-nagoya (1362delG), while their parents with its heterozygous mutation were asymptomatic. Most of the PC-deficient patients developed intracranial lesion and/or purpura fulminans within 2 weeks after birth. Non-inherited PC deficiency also conveyed thromboembolic events in early infancy. The molecular epidemiology of thrombosis in Asian children would provide a clue to establish the early intervention and optimal anticoagulant therapy in pediatric PC deficiency.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adolescent
  • Anticoagulants / therapeutic use
  • Antithrombins / blood
  • Blood Coagulation Tests
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Early Diagnosis
  • Early Medical Intervention
  • Humans
  • Infant
  • Infant, Newborn
  • Japan
  • Protein C / metabolism
  • Protein C Deficiency / blood
  • Protein C Deficiency / diagnosis
  • Protein C Deficiency / drug therapy
  • Protein S / metabolism
  • Protein S Deficiency / blood
  • Protein S Deficiency / diagnosis
  • Protein S Deficiency / drug therapy
  • Protein S Deficiency / genetics*
  • Reference Values
  • Thrombophilia / blood
  • Thrombophilia / diagnosis
  • Thrombophilia / genetics

Substances

  • Anticoagulants
  • Antithrombins
  • Protein C
  • Protein S

Supplementary concepts

  • Antithrombin deficiency type 2
  • Thrombophilia, Hereditary, Due To Protein S Deficiency, Autosomal Recessive